Anal Fissure Treatment Market Synopsis

Anal Fissure Treatment Market Size Was Valued at USD 1.62 Billion in 2023, and is Projected to Reach USD 3.05 Billion by 2032, Growing at a CAGR of 18.20% From 2024-2032.

The market for anal fissure treatment is developing due to the popularity of this rather painful pathology. An anal fissure is a break in the anus lining and may be caused by a hard motion, prolonged diarrhoea or childbirth. These cracks can bring a lot of discomfort and dyschezia, as well as pain during and after defecation, and may be accompanied by bleeding. Consequently, people look for right methods of combating these conditions and regaining health and strength. The analysed market is mainly driven by the higher frequency of anal fissures in patients with various gastrointestinal diseases, pregnant women, as well as elderly people.

• This anal fissure treatment market has been classified into two which are non surgical treatment and surgical treatment. Ointments containing nitroglycerin, oral calcium channel blockers and stool softening agents are mostly used in the management of pain and healing. In more severe cases surgery includes lateral internal sphincterotomy as a procedure that relieves muscular contractions and recurrence. Cosmetic surgery also seems to be being replaced, to a certain extent, with non-surgical procedures such as Botox. The market is gradually drifting towards these more sophisticated techniques that involve minimal invasions and equally have shorter recovery time and low risk of complications.
• As more improved medical technologies are developed, and other treatment procedures are advanced, there would be increased need for anal fissure treatments hence the growth of the market. However, certain challenges have been witnessed in the market such as; high costs associated with surgery and inadequate availability of specialized treatment solutions in some parts of the world. When public awareness increases, and as the consumer market expands and more treatments come into common use, there is further scope for advance made in actual patient care and the over all results which are achieved.

Anal Fissure Treatment Market Trend Analysis

Shift Toward Minimally Invasive Treatments

• The global anal fissure treatment market is steadily growing due to the innovation towards minimally invasive treatments. Conventional endoscopic management which includes lateral internal sphincterotomy though helpful entails a longer recovery period not forgetting the possible side effects. That is why there is a move to less invasive methods – Botox injections, laser treatments, other novelties that allow the patient to recover more quickly with minimal risk. These procedures assist in minimizing the patients’ discomfort as well as the number of days they spend in hospitals; thus, enhancing the attractiveness of these procedures to both healthcare service providers and consumers.

 Increasing Adoption of Topical Therapies

• The development of topical therapies to treat anal fissure has also been emerging in the market more often than before. Nitroglycerin ointments and calcium channel blockers, lidocaine-based creams are the standard topical medication prescriptions that are used for treating pain or for the healing process. Such treatments are becoming popular due to their contact nature, cost, and impact compared to the usual operations. Increased focus on conservative treatments, especially in mild to moderate cases of anal fissures is responsible for the growing demand of such treatment methods especially the non surgical ones especially in outpatients and home based care.

Anal Fissure Treatment Market Segment Analysis:

Anal Fissure Treatment Market is segmented on the basis of By Treatment Type , By Route of Administration and By Distribution Channel.

By Treatment Type, Laxatives segment is expected to dominate the market during the forecast period

• By treatment type, the anal fissure treatment market is divided into several categories to meet different levels of the patient’s condition. These enteral medications benefit patients in cases where constipation or hard stools play a role in fissure development and where the use of suppositories or stressful bowel movements is avoided. Topical nitrates and calcium channel blockers may be prescribed to relax the anal sphincter muscles and help the fissure to heal. In more severe cases, an operation, including lateral internal sphincterotomy, may be required to eliminate muscle spasms and avoid a relapse. Also, other therapies such as injection of Botox or laser therapy are becoming more common as non-surgical approaches to encourage tissue repair and alleviate suffering, as compared to conventional surgeries. Varying types of treatment also enable the necessary procedures to be chosen according to the patient condition and his reaction to the therapy.

By Distribution Channel, Hospital Pharmacies segment expected to held the largest share

• The global anal fissure treatment market based on distribution channel has been categorized into hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy is the most important component for delivering prescription-based medicines, especially for the severe conditions especially requiring complicated or surgical solutions. There are retail pharmacies which act as distribution outlets for OTC products such as topical agents, remedies for constipation and minor pain products. It is popular for Filipinos to trust online pharmacy stores because of the booming business of e-commerce and home delivery, conveniences that give patients affordable prices for both prescribed and over-the-counter prescribed medications. This channels of distribution make it possible for the patients to get a variate number of treatments, thus enhancing the growth of anal fissure treatment market.

Anal Fissure Treatment Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America should remain the largest market for anal fissure treatment for the duration of the forecast period mainly as a result of a high incidence of gastrointestinal disorders including chronic constipation and hemorrhoids that are the leading causes of anal fissures. There is developed health care system foundation, high availability of modern treatment methods, shift in paradigm towards patient centric approach which in turns improving the treatment opportunities like non invasive procedures and superior topical application therapies. Moreover, the increasing presence of market players, a favorable reimbursement policies framework, and enhancing population awareness of anal fissures in the country are predicted to boost the growth of the market in North America throughout the forecast period.

Active Key Players in the Anal Fissure Treatment Market

• AbbVie (USA)
• Novartis AG (Switzerland)
• Teva Pharmaceuticals (Israel)
• Troikaa (India)
• RDD Pharma, Ltd (USA)
• Kyowa Kirin Co., Ltd (Japan)
• Cipla Inc. (India)
• Ipsen Pharma (France)
• Sanofi (France)
• Boehringer Ingelheim International GmbH (Germany)
• Bliss GVS (India)
• SRS Life Sciences (India)
• Healthy Life Pharma Private Limited (India)
• GeriCare Pharmaceuticals Corp. (USA)
• Others

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Anal Fissure Treatment Market by Treatment Type
 4.1 Anal Fissure Treatment Market Snapshot and Growth Engine
 4.2 Anal Fissure Treatment Market Overview
 4.3 Laxatives
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Laxatives: Geographic Segmentation Analysis
 4.4 Topical Nitrates
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Topical Nitrates: Geographic Segmentation Analysis
 4.5 Calcium Channel Blockers
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Calcium Channel Blockers: Geographic Segmentation Analysis
 4.6 Stool Softeners
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Stool Softeners: Geographic Segmentation Analysis
 4.7 Surgery
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Surgery: Geographic Segmentation Analysis
 4.8 Others
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Others: Geographic Segmentation Analysis

Chapter 5: Anal Fissure Treatment Market by Route of Administration
 5.1 Anal Fissure Treatment Market Snapshot and Growth Engine
 5.2 Anal Fissure Treatment Market Overview
 5.3 Oral
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Oral: Geographic Segmentation Analysis
 5.4 Topical
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Topical: Geographic Segmentation Analysis
 5.5 Others
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Others: Geographic Segmentation Analysis

Chapter 6: Anal Fissure Treatment Market by Distribution Channel
 6.1 Anal Fissure Treatment Market Snapshot and Growth Engine
 6.2 Anal Fissure Treatment Market Overview
 6.3 Hospital Pharmacies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
 6.4 Retail Pharmacies
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Retail Pharmacies: Geographic Segmentation Analysis
 6.5 Online Pharmacies
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Online Pharmacies: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Anal Fissure Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ABBVIE (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 NOVARTIS AG (SWITZERLAND)
 7.4 TEVA PHARMACEUTICALS (ISRAEL)
 7.5 TROIKAA (INDIA)
 7.6 RDD PHARMA
 7.7 LTD (USA)
 7.8 KYOWA KIRIN CO LTD (JAPAN)
 7.9 CIPLA INC (INDIA)
 7.10 IPSEN PHARMA (FRANCE)
 7.11 SANOFI (FRANCE)
 7.12 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
 7.13 BLISS GVS (INDIA)
 7.14 SRS LIFE SCIENCES (INDIA)
 7.15 HEALTHY LIFE PHARMA PRIVATE LIMITED (INDIA)
 7.16 GERICARE PHARMACEUTICALS CORP (USA)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global Anal Fissure Treatment Market By Region
 8.1 Overview
 8.2. North America Anal Fissure Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Treatment Type
  8.2.4.1 Laxatives
  8.2.4.2 Topical Nitrates
  8.2.4.3 Calcium Channel Blockers
  8.2.4.4 Stool Softeners
  8.2.4.5 Surgery
  8.2.4.6 Others
  8.2.5 Historic and Forecasted Market Size By Route of Administration
  8.2.5.1 Oral
  8.2.5.2 Topical
  8.2.5.3 Others
  8.2.6 Historic and Forecasted Market Size By Distribution Channel
  8.2.6.1 Hospital Pharmacies
  8.2.6.2 Retail Pharmacies
  8.2.6.3 Online Pharmacies
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Anal Fissure Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Treatment Type
  8.3.4.1 Laxatives
  8.3.4.2 Topical Nitrates
  8.3.4.3 Calcium Channel Blockers
  8.3.4.4 Stool Softeners
  8.3.4.5 Surgery
  8.3.4.6 Others
  8.3.5 Historic and Forecasted Market Size By Route of Administration
  8.3.5.1 Oral
  8.3.5.2 Topical
  8.3.5.3 Others
  8.3.6 Historic and Forecasted Market Size By Distribution Channel
  8.3.6.1 Hospital Pharmacies
  8.3.6.2 Retail Pharmacies
  8.3.6.3 Online Pharmacies
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Anal Fissure Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Treatment Type
  8.4.4.1 Laxatives
  8.4.4.2 Topical Nitrates
  8.4.4.3 Calcium Channel Blockers
  8.4.4.4 Stool Softeners
  8.4.4.5 Surgery
  8.4.4.6 Others
  8.4.5 Historic and Forecasted Market Size By Route of Administration
  8.4.5.1 Oral
  8.4.5.2 Topical
  8.4.5.3 Others
  8.4.6 Historic and Forecasted Market Size By Distribution Channel
  8.4.6.1 Hospital Pharmacies
  8.4.6.2 Retail Pharmacies
  8.4.6.3 Online Pharmacies
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Anal Fissure Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Treatment Type
  8.5.4.1 Laxatives
  8.5.4.2 Topical Nitrates
  8.5.4.3 Calcium Channel Blockers
  8.5.4.4 Stool Softeners
  8.5.4.5 Surgery
  8.5.4.6 Others
  8.5.5 Historic and Forecasted Market Size By Route of Administration
  8.5.5.1 Oral
  8.5.5.2 Topical
  8.5.5.3 Others
  8.5.6 Historic and Forecasted Market Size By Distribution Channel
  8.5.6.1 Hospital Pharmacies
  8.5.6.2 Retail Pharmacies
  8.5.6.3 Online Pharmacies
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Anal Fissure Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Treatment Type
  8.6.4.1 Laxatives
  8.6.4.2 Topical Nitrates
  8.6.4.3 Calcium Channel Blockers
  8.6.4.4 Stool Softeners
  8.6.4.5 Surgery
  8.6.4.6 Others
  8.6.5 Historic and Forecasted Market Size By Route of Administration
  8.6.5.1 Oral
  8.6.5.2 Topical
  8.6.5.3 Others
  8.6.6 Historic and Forecasted Market Size By Distribution Channel
  8.6.6.1 Hospital Pharmacies
  8.6.6.2 Retail Pharmacies
  8.6.6.3 Online Pharmacies
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Anal Fissure Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Treatment Type
  8.7.4.1 Laxatives
  8.7.4.2 Topical Nitrates
  8.7.4.3 Calcium Channel Blockers
  8.7.4.4 Stool Softeners
  8.7.4.5 Surgery
  8.7.4.6 Others
  8.7.5 Historic and Forecasted Market Size By Route of Administration
  8.7.5.1 Oral
  8.7.5.2 Topical
  8.7.5.3 Others
  8.7.6 Historic and Forecasted Market Size By Distribution Channel
  8.7.6.1 Hospital Pharmacies
  8.7.6.2 Retail Pharmacies
  8.7.6.3 Online Pharmacies
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research